Back

Outcomes of patients undergoing catheter ablation to treat atrial fibrillation using zero-fluoroscopy vs conventional approach.

31 March 2025 (14:30 - 15:15)
Organised by: Logo
Congress Presentation Part of: Invasive treatment of atrial fibrillation Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Daniela Hincapie

Boston (United States of America)

6 More presentations in this session

Presentation thumbnail
A prospective randomized clinical comparison of catheter ablation of atrial fibrillation using the CENTAURI PEF system and standard radiofrequency ablation
Doctor Z. Starek (Brno, CZ)
Abstract Slides Video
Presentation thumbnail
Visualizable vs. non-visualizable sheaths for atrial fibrillation ablation procedures: a systematic review and meta-analysis
Doctor D. Torma (Pecs, HU)
Abstract Slides Video
Presentation thumbnail
Panoramic atrial mapping offers advantages in the treatment of persistent atrial fibrillation compared with standard pulmonary vein isolation
Doctor R. Gagyi (Szeged, HU)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes of patients treated with pulsed field ablation under the first-in-human clinical trials with prospective invasive remap
Doctor I. Sikiric (Split, HR)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation re-ablation: a comparative analysis of the efficacy of initial PVI procedures
Mr D. Inacio Cazeiro (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Invasive treatment of atrial fibrillation

The Event

Event poster

EHRA 2025

31 March 2025 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Procedural outcomes of fluoroscopy-less catheter ablation for atrial fibrillation
thumbnail
Congress Presentation
Safety and feasibility of zero-fluoroscopy technique in ablation-index guided pulmonary vein isolation: a prospective, single center trial
thumbnail
Congress Presentation
Fluoroscopy-free atrial fibrillation ablation using pulsed field ablation system

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources